2004 Annual Meeting | Child Neurology II

Date Tuesday 04/27/04

Time 02:15 PM - 06:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type PM Half-Day Course

Director(s) Harvey S. Singer, MD, F�鶹��ýӳ��

Topic(s) Child Neurology and Developmental Neurology

Learning Objectives Upon completion:
Participants should be able to define the presentation and diagnostic evaluation of different categories of metabolic disorders and discuss the differential diagnosis, physiology, and pharmacological aspects of dystonia, tremors, and Tourette syndrome.

The American Board of Psychiatry and Neurology has reviewed Child Neurology II and has approved this product as part of a comprehensive lifelong learning program, which is mandated by the ABMS as a necessary component of maintenance of certification.

CME Available No CME available

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
02:15 PM - 03:00 PM		Presentation and Evaluation of Metabolic Disorders Causing Neurological Problems Tyler E. Reimschisel, MD, MHPE
03:00 PM - 03:45 PM		Tremors in Childhood Leon S. Dure, MD
03:45 PM - 04:00 PM		Break
04:00 PM - 04:45 PM		Tourette Syndrome and Related Disorders Harvey S. Singer, MD, F�鶹��ýӳ��
04:45 PM - 05:30 PM		Dystonia in Childhood Jonathan W. Mink, MD, PhD, F�鶹��ýӳ��
05:30 PM - 06:00 PM		Case Studies

Faculty Disclosures
Jonathan W. Mink, MD, PhD, F�鶹��ýӳ��	The institution of Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. The institution of Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Mink has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics. Dr. Mink has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for �鶹��ýӳ��. The institution of Dr. Mink has received research support from Neurogene. The institution of Dr. Mink has received research support from NIH. Dr. Mink has received publishing royalties from a publication relating to health care. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Member, Study Section with NINDS.
Harvey S. Singer, MD, F�鶹��ýӳ��	No disclosure on file
	No disclosure on file
Leon S. Dure, MD	Dr. Dure has nothing to disclose.
Tyler E. Reimschisel, MD, MHPE	No disclosure on file